1	subject have be maintain on a stable dose regimen of 1 to 2 non-benzodiazepine market anti-epileptic drug aeds or 1 to 3 aeds with at least 1 aed identify a a benzodiazepine for at least 28 day prior to visit 1 with or without additional concurrent stable vagus nerve stimulation vns|benzodiazepine[64,78]||||||||||1402|1402|benzodiazepine
1	subject have be maintain on a stable dose regimen of 1 to 2 non-benzodiazepine market anti-epileptic drug aeds or 1 to 3 aeds with at least 1 aed identify a a benzodiazepine for at least 28 day prior to visit 1 with or without additional concurrent stable vagus nerve stimulation vns|benzodiazepine[159,173]|||||||28 day[187,193]|||1402|1402|benzodiazepine
